PharmaCare Named National Distribution Partner for MedImmune's 2003/2004 Synagis Distribution Network.Business Editors/Health/Medical Writers LINCOLN, R.I.--(BUSINESS WIRE)--Aug. 14, 2003 PharmaCare Management Services, Inc., announced today that its specialty pharmacy division, CVS (1) (Concurrent Versions System) A version control system for Unix that was initially developed as a series of shell scripts in the mid-1980s. CVS maintains the changes between one source code version and another and stores all the changes in one file. ProCare, has been selected by MedImmune, Inc. to be a national specialty pharmaceutical distributor of its drug Synagis(R) (palivizumab). Synagis is indicated for the prevention of serious lower respiratory tract Noun 1. lower respiratory tract - the bronchi and lungs lung - either of two saclike respiratory organs in the chest of vertebrates; serves to remove carbon dioxide and provide oxygen to the blood disease caused by respiratory syncytial virus respiratory syncytial virus (sĭnsĭsh`əl): see cold, common. (RSV RSV respiratory syncytial virus; Rous sarcoma virus. RSV abbr. respiratory syncytial virus RSV 1 Respiratory syncytial virus, see there 2 Rous sarcoma virus, see there ) in pediatric patients at high risk for RSV (see full prescribing information at www.medimmune.com). RSV is the leading cause of infant hospitalization in the U.S., and according to a recent study by the Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), agency of the U.S. Public Health Service since 1973, with headquarters in Atlanta; it was established in 1946 as the Communicable Disease Center. , RSV is the leading viral cause of infant death. CVS ProCare was selected as a national network provider for Synagis because it has the ability to provide the support needed to maintain the highest quality of customer service MedImmune demands for its patients. "We've worked hard at building a reputation for quality. Our inclusion as a national provider of this very important drug is something for which we are quite proud," said Greg Weishar, President of PharmaCare. "With the addition of Synagis, CVS ProCare has now earned either an exclusive or preferred distributor status for six specialty drugs. Our long history in specialty pharmacy and substantial market presence are what make us attractive partners for both health plans and manufacturers alike." About PharmaCare PharmaCare, a leading prescription benefit manager (PBM), provides integrated network pharmacy claims processing, mail pharmacy services, specialty pharmaceuticals, benefit design consultation, drug utilization review drug utilization review Health insurance A study of drug prescriptions to evaluate appropriateness and cost-effectiveness of drug therapy , formulary management, disease management and medical drug data analysis services to over 15 million participants throughout the U.S. PharmaCare's clients include managed care organizations, insurance companies, corporate health plans, unions, government agencies and other funded benefit plans. PharmaCare is a subsidiary of CVS Corporation (NYSE NYSE See: New York Stock Exchange : CVS). More information can be found at http://www.pharmacare.com. Synagis is a registered trademark of MedImmune, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion